Kypha Inc.
Pharmaceutical company · Saint Louis, Missouri, United States
Kypha Inc. is a pharmaceutical company headquartered in Saint Louis, Missouri, United States. Its earliest recorded incorporation is in 2009. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $491,728 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $5.2 million sold in a notice filed in 2022.
Kypha at a glance
What does Kypha do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $491,728 in total (2011 to 2016). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $5.2 million sold (2022).
Frequently asked questions about Kypha
Where is Kypha headquartered?
Kypha Inc. is headquartered in Saint Louis, Missouri, United States.
What does Kypha do?
Kypha Inc. is a pharmaceutical company.
When was Kypha founded?
The earliest incorporation on record for Kypha Inc. is in 2009, according to public company registers.
Similar companies
- Immunophotonics, Inc.St. Louis, Missouri, United States
- Euclises Pharmaceuticals, Inc.St. Louis, Missouri, United States
- Indalo Therapeutics, Inc.St. Louis, Missouri, United States
- Aperta Biosciences, LLCSt. Louis, Missouri, United States
- Reliable Biopharmaceutical CorporationSt. Louis, Missouri, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences